| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |